Глобалниот течна биопсија пазарот беше ценет во 1.3 милијарди УСД in 2020. By 2031, it is estimated that it will reach 6.9 милијарди УСД. Ова претставува а 20.8% annual growth rate from 2022 to 2031.
Растечката побарувачка
Asia-Pacific is projected to experience significant growth over the 2022-2029 forecast period. This is due to rising government awareness programs, medical tourism, increasing research activities in Asia-Pacific, rising cancer cases, and the growing demand for quality healthcare.
Добијте примерок од извештај за да добиете сеопфатен увид @ https://market.us/report/liquid-biopsy-market/request-sample/
The country section of this report provides information on market-influencing factors and changes in domestic regulations that will impact market trends. To forecast the market for particular countries, data points like the downstream and the upstream value chain analysis as well as technology trends and porter’s five force analysis are used. Forecast analysis of country data also considers the presence and limitations of global brands and the challenges they face due to the competition from domestic and local brands.
Фактори за возење
Over the forecast period, the main driving factors for the United States liquid biopsy market are the increase in patient preference and cancer patients.
Ограничувачки фактори
However, market growth is expected to be hindered by the high costs associated with research and development professionals, the limited infrastructure facilities, and the lower sensitivity of liquid biopsies. The low reimbursement rate and low penetration of technology in developing countries will also be affected the market growth.
This market report on liquid biopsy provides detailed information about the latest developments, trade regulations, import-export analyses, production analysis, and value chain optimization. It also analyses the impact of localized market players. For more information on the liquid biopsy market, please contact Data Bridge Market Research. We will provide you with an Analyst Brief.
Неодамнешен развој
- Guardant Health, Inc. (US) introduced its Guardant360 response test, which detects changes in the circulating tumor DNA (ctDNA).
- F. Hoffmann-La Roche Ltd., Switzerland, received FDA approval in October 2020 for expanded claims to the Cobas EGFR Mutation Test v2 that can be used as a companion diagnosis (CDx) for a wider variety of therapies for non-small-cell lung carcinoma (NSCLC).
- Biocept, Inc. (US) reached an agreement with a California-based independent physician association (IPA) in March 2020 to provide Target Selector liquid biopsy testing services to doctors and patients within the network.
Клучни компании
- RainDanceTechnologies
- Биокартис
- Здравје чувар
- MDxЗдравје
- Pathway Genomics
- NeoGenomics Laboraories
- Sysmex Inostics
- Cynvenio
- Menarini Silicon Biosystems
- Кјаген
- Адаптивни биотехнологии
- Биоцепт
- Angle plc
Клучни сегменти на пазарот
тип
- ДТЦ
- ctDNA
- Егзозоми
апликација
- Blood Sample based
- Urine Sample based
- Bio Fluids based
Најчесто поставувани прашања
- What are the most recent trends in the liquid biopsy?
- What are the most critical areas for liquid biopsy?
- Who are the major players in the liquid biopsy?
- Who are the top end users for liquid biopsy products & related services?
- Which region is the most lucrative for liquid biopsies?
Поврзан извештај:
Global Breast Cancer Liquid Biopsy Market Фактори за раст на индустријата, типови и апликации Регионална анализа Клучни играчи и прогноза до 2031 година
Global Liquid Biopsy Products Market Истражување 2022 година Регионалниот сегмент на индустријата по производство на потрошувачка Приходи со продажба и стапка на раст
Global Lung Cancer Liquid Biopsy Market Истражување 2022 Големина на индустријата Клучни играчи споделуваат анализа на трендови и прогноза за раст до 2031 година
Global Breast Biopsy Device Market По региони на производители Типови производи Примена и прогноза до 2031 година
За Market.us
Market.US (Powered by Prudour Private Limited) е специјализиран за длабинско истражување и анализа. Оваа компанија се докажува како водечки консултантски и прилагоден истражувач на пазарот и високопочитуван синдициран добавувач на извештаи за истражување на пазарот.
Контакт детали:
Тим за развој на глобален бизнис – Market.us
Market.us (Напојувано од Prudour Pvt. Ltd.)
Адреса: Авенија Лексингтон 420, пакет 300 Newујорк, NYујорк 10170, САД
Телефон: +1 718 618 4351 (меѓународен), телефон: +91 78878 22626 (Азија)
Е-пошта: [заштитена по е-пошта]
ШТО ДА ОДЗЕМЕ ОД ОВАА НАСТАП:
- (US) reached an agreement with a California-based independent physician association (IPA) in March 2020 to provide Target Selector liquid biopsy testing services to doctors and patients within the network.
- This company has been proving itself as a leading consulting and customized market researcher and a highly-respected syndicated market research report provider.
- Over the forecast period, the main driving factors for the United States liquid biopsy market are the increase in patient preference and cancer patients.
